Figure 15. Gonorrhea - Rates by race and ethnicity: United States, 1981-2004 and the Healthy People 2010 target


Note: The Healthy People 2010 target for gonorrhea is 19.0 cases per 100,000 population.

Figure 16. Gonorrhea - Age- and sex-specific rates: United States, 2004

Figure 17. Gonorrhea - Age-specific rates among women 10 to 44 years of age: United States, 1981-2004

Figure 18. Gonorrhea - Age-specific rates among men 10 to 44 years of age: United States, 1981-2004

Figure 19. Gonorrhea - Positivity among 15- to 24-year-old women tested in family planning clinics by state: United States and outlying areas, 2004

*States/areas reported gonorrhea positivity data on less than 500 women aged 15-24 years during 2004. Note: Includes states that reported gonorrhea positivity data on at least 500 women aged 15-24 years screened during 2004 except for Maine, which submitted gonorrhea positivity data for April-December 2004, and Minnesota which submitted gonorrhea positivity data for January-March and July-December 2004.
SOURCE: Regional Infertility Prevention Projects; Office of Population Affairs; Local and State STD Control Programs; Centers for Disease Control and Prevention

Figure 20. Gonococcal Isolate Surveillance Project (GISP) - Location of participating clinics and regional laboratories: United States, 2004

Figure 21. Gonococcal Isolate Surveillance Project (GISP) - Penicillin and tetracycline resistance among GISP isolates, 2004

Note: PPNG=penicillinase-producing N. gonorrhoeae; TRNG=plasmid-mediated tetracycline-resistant N. gonorrhoeae; PPNG-TRNG=plasmid-mediated penicillin and tetracycline-resistant N. gonorrhoeae; PenR=chromosomally mediated penicillin-resistant N. gonorrhoeae; TetR= chromosomally mediated tetracycline-resistant N. gonorrhoeae; CMRNG=chromosomally mediated penicillin- and tetracycline-resistant N. gonorrhoeae.

Figure 22. Gonococcal Isolate Surveillance Project (GISP) - Percent of Neisseria gonorrhoeae isolates with resistance or intermediate resistance to ciprofloxacin, 1990-2004

Note: Resistant isolates have ciprofloxacin MICs ≥ 1 µg/ml. Isolates with intermediate resistance have ciprofloxacin MICs of 0.125 - 0.5 µg/ml. Susceptibility to ciprofloxacin was first measured in GISP in 1990.

Figure 23. Gonococcal Isolate Surveillance Project (GISP) - Percent of Neisseria gonorrhoeae isolates with resistance to ciprofloxacin by sexual behavior, 2001-2004